Off-Duty Cannabis Protections — State by State

Last verified: April 2026

What “Off-Duty Protection” Means

An off-duty cannabis protection statute does three things, roughly: it limits what an employer can do about lawful off-duty cannabis use, it limits the kinds of drug tests an employer can rely on, and it provides a remedy (usually a private right of action) when an employer crosses the line.

What these laws do not do: they do not allow on-the-clock use, they do not protect impaired workers, they do not eliminate post-accident testing in most frameworks, and they do not override federal requirements for DOT-regulated workers, federal contractors, and federal employees.

California — AB 2188 and SB 700

AB 2188, effective January 1, 2024, is the most comprehensive off-duty cannabis protection law in the country. It prohibits employers from discriminating against an employee based on the employee’s use of cannabis off the job and away from the workplace, and it specifically bans reliance on tests that detect only nonpsychoactive metabolites. That second piece is what effectively retires old-style urine tests for most private-sector California employers when it comes to cannabis.

SB 700 goes further: it prohibits employers from even asking applicants about their past cannabis use. A California interview that opens with “have you ever used marijuana” is a statutory violation.

Both laws include carve-outs for federal contractors, workers in the building and construction trades, and positions requiring federal background checks or security clearances.

The Other Eight States

Eight additional adult-use states have enacted off-duty cannabis protections with broadly similar structures. The specific statutory language varies, and so do the enforcement remedies, but the common floor is: lawful off-duty use cannot, by itself, be the sole basis for hiring, firing, or disciplinary action.

• Connecticut — protections enacted alongside adult-use legalization.
• Nevada — bars pre-employment cannabis screens for most positions; narrow safety-sensitive exceptions.
• New Jersey — strong statute with explicit remedies for workers.
• New York — MRTA-era protections, among the strongest in the country.
• Minnesota — comprehensive protections enacted with adult-use legalization.
• Montana — baseline off-duty protections with safety-sensitive exceptions.
• Rhode Island — protections built into the state’s adult-use framework.
• Washington — limits pre-employment screens for non-safety-sensitive roles.

Who’s Exempt

In every state with off-duty protections, the same general categories of workers are carved out:

• Construction workers — safety-sensitive work tied to OSHA requirements and insurance frameworks.
• Federal contractors — bound by the Drug-Free Workplace Act.
• DOT-regulated transportation — commercial drivers, pilots, railroad workers, maritime. Federally mandated testing regime.
• Federal employees — state law cannot override federal employment requirements.
• Security clearance holders — a cannabis-positive test can cost a clearance regardless of state law.
• Positions where federal law specifically requires testing — nuclear, certain healthcare, certain aviation.

States Without Off-Duty Protections

Many legal states — including large markets like Illinois, Michigan, and Massachusetts — have legalized adult-use cannabis but have not enacted comprehensive off-duty employment protections. In those states, employer policy controls. A worker can legally buy and consume cannabis at home on Saturday and still be lawfully fired for a positive Monday-morning urine test.

This is one of the largest gaps in the current legal landscape and one of the areas where state legislatures are most likely to act over the next few sessions. If you are in a state without off-duty protections, your best information source is your employer’s written drug and alcohol policy — not your state’s legalization statute.

The Federal Layer

Federal law continues to classify cannabis as Schedule I. In December 2025, President Trump signed an executive order directing rescheduling to Schedule III, but the process remains incomplete as of April 2026. Even when completed, Schedule III rescheduling is unlikely to alter employer drug-free workplace policies or the federal-contractor testing regime in the near term. See our workplace overview for more on the federal piece.